Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Aug;198(4):753-764.
doi: 10.1111/bjh.18291. Epub 2022 Jun 3.

Menstrual problems in chronic immune thrombocytopenia: A monthly challenge - a cohort study and review

Affiliations
Review

Menstrual problems in chronic immune thrombocytopenia: A monthly challenge - a cohort study and review

Wobke E M van Dijk et al. Br J Haematol. 2022 Aug.

Abstract

Immune thrombocytopenia (ITP) may cause menstrual problems. This cross-sectional study assessed menstrual problems in premenopausal chronic ITP women by several questionnaires, including the pictorial bleeding assessment calendar (PBAC; score ≥100 indicates heavy menstrual bleeding [HMB]), and the menorrhagia multiattribute scale (MMAS). Spearman was used for assessing correlations. A literature review was performed in Pubmed. The cohort comprised 37 women (mean age 31 ± 9). A total of 29/37 (78%) had experienced clinical menstrual problems in the present or past. Of the 33 patients who returned the PBAC, 13 (39%) had a score of ≥100. The median MMAS score was 79 (IQR 60-95). The PBAC scores correlated with the MMAS. Both questionnaires were unrelated to the platelet count. Patients with a levonorgestrel intrauterine device (LNG-IUD) had lower PBAC scores than patients with other or no hormonal therapy. MMAS scores were correlated with fatigue. The review identified 14 papers. HMB occurred in 6%-55% at ITP diagnosis and 17%-79% during disease. Menstrual symptoms influenced the quality of life, particularly in patients with a low platelet count. This explorative study suggested that HMB is frequent in women with chronic ITP despite management and platelet counts >50 *109 /l. An LNG-IUD seemed to reduce blood loss significantly.

Keywords: heavy menstrual bleeding; immune thrombocytopenia; menstrual problems; menstruation; quality of life.

PubMed Disclaimer

Conflict of interest statement

R.E.G. Schutgens received a grant from Novartis. The other authors have no potential conflicts of interest to declare.

Figures

FIGURE 1
FIGURE 1
The (A) pictorial bleeding assessment calendar (PBAC) and (B) menorrhagia multiattribute scale (MMAS) scores per contraceptive group. The “other”‐group includes one patient with contraceptive injections and one patient with a vaginal ring (NuvaRing). LNG‐IUD, Levonorgestrel intrauterine device; OCP, Oral contraceptive pills.
FIGURE 2
FIGURE 2
The (A) pictorial bleeding assessment calendar (PBAC) and (B) menorrhagia multiattribute scale (MMAS) scores in relation to the platelet count. [Colour figure can be viewed at wileyonlinelibrary.com]
FIGURE 3
FIGURE 3
PRISMA flowchart of study selection. [Colour figure can be viewed at wileyonlinelibrary.com]

Similar articles

Cited by

References

    1. Lambert MP, Gernsheimer TB. Clinical updates in adult immune thrombocytopenia. Blood. 2017;129(21):2829–35. - PMC - PubMed
    1. Arnold DM. Bleeding complications in immune thrombocytopenia. Hematology. 2015;2015(1):237–42. - PubMed
    1. Ghoshal K, Bhattacharyya M. Overview of platelet physiology: its hemostatic and nonhemostatic role in disease pathogenesis. Hindawi. 2014;2014:1–16. - PMC - PubMed
    1. Cooper N, Kruse A, Kruse C, Watson S, Morgan M, Provan D, et al. Immune thrombocytopenia (ITP) world impact survey (I‐WISh): patient and physician perceptions of diagnosis, signs and symptoms, and treatment. Am J Hematol. 2021;96(2):188–98. - PMC - PubMed
    1. ACOG practice bulletin: management of anovulatory bleeding. Int J Gynaecol Obstet. 2001;72(3):263–71. - PubMed

Publication types